Study on optimize the preparation and formulation of nimodipine-containing nanoliposome

Journal of China Pharmaceutical University

Volumn 34, Issue 1, 2003, Pages 25-28

  Zhang, Gui Fang ^a   Zhu, Jia Bi ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Nanoliposome; Nimodipine; Orthogonal design

Indexed keywords

ALCOHOL; CHOLESTEROL; DEOXYCHOLATE SODIUM; LIPOSOME; MANNITOL; NIMODIPINE; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SOLID LIPID NANOPARTICLE;

ARTICLE; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; PARTICLE SIZE;

EID: 30044451498     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. William M Pardridge. Transport of small molecules through the blood-brain barrier: biology and methodology[J]. Advanced Drug Delivery Review, 1995,15:5-36.
2. Schackert G, Fan D, Nayar R, et al. Arrest and retention of multilamellar liposomes in the brain of normal mice or mice bearing experimental brain metastases[J]. Selective Cancer Ther, 1989,5:73-79.
3. Micklus MJ, Greig NH, Tung J, et al. Organ distribution of liposomal formulations following intracarotid infusion in rats [J]. Biochim Biophys Acta, 1992,1124: 7-12.
4. Massimo Fresta, Giovanni Puglisi, Claudia Di Giacomo, et al. Liposomes as In-vivo Carriers for Citicoline: Effects on Rat Cerebral Post-ischaemic Reperfusion [J]. J Pharm Pharmacol, 1994, 46:974-981.
5. Gennuso R, Spigelman MK, Chinol M, et al. Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake[J]. Cancer Invest, 1993,11:118-128.
6. Zhang HY. Chin Pharm J, 1998,33(7):415-417.
7. Guo JX, Ping QN, Huang LS. J Chin Pharm Univ, 1999,30(3):187-191.